HEADER TRANSCRIPTION 21-JUN-05 2A24 TITLE HADDOCK STRUCTURE OF HIF-2A/ARNT PAS-B HETERODIMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOTHELIAL PAS DOMAIN PROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL PAS DOMAIN (PAS-B); COMPND 5 SYNONYM: EPAS-1, MEMBER OF PAS PROTEIN 2, MOP2, HYPOXIA-INDUCIBLE COMPND 6 FACTOR 2 ALPHA, HIF-2 ALPHA, HIF2 ALPHA, HIF-1 ALPHA-LIKE FACTOR, COMPND 7 HLF; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: C-TERMINAL PAS DOMAIN (PAS-B); COMPND 12 SYNONYM: ARNT PROTEIN, DIOXIN RECEPTOR, NUCLEAR TRANSLOCATOR, COMPND 13 HYPOXIA-INDUCIBLE FACTOR 1 BETA, HIF-1 BETA SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 7 ORGANISM_COMMON: HUMAN; SOURCE 8 ORGANISM_TAXID: 9606 KEYWDS ARNT, HIF, HYPOXIA, TRANSCRIPTION, PAS EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR P.B.CARD,P.J.ERBEL,K.H.GARDNER REVDAT 5 22-MAY-24 2A24 1 REMARK REVDAT 4 09-MAR-22 2A24 1 REMARK REVDAT 3 24-FEB-09 2A24 1 VERSN REVDAT 2 22-AUG-06 2A24 1 EXPDTA REMARK REVDAT 1 17-JAN-06 2A24 0 JRNL AUTH P.B.CARD,P.J.ERBEL,K.H.GARDNER JRNL TITL STRUCTURAL BASIS OF ARNT PAS-B DIMERIZATION: USE OF A COMMON JRNL TITL 2 BETA-SHEET INTERFACE FOR HETERO- AND HOMODIMERIZATION. JRNL REF J.MOL.BIOL. V. 353 664 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 16181639 JRNL DOI 10.1016/J.JMB.2005.08.043 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : HADDOCK 1.2, CNS 1.1 REMARK 3 AUTHORS : BONVIN (HADDOCK), REMARK 3 BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE,JIANG,KUSZEWSKI, REMARK 3 NILGES, PANNU,READ,RICE,SIMONSON,WARREN (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2A24 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUL-05. REMARK 100 THE DEPOSITION ID IS D_1000033396. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : 7.5 REMARK 210 IONIC STRENGTH : 50MM TRIS, 17MM NACL, 5MM DTT REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 250 MICRO M (15N)HIF-2ALPHA PAS REMARK 210 -B (240-350) + 1MM ARNT PAS-B REMARK 210 (356-470), 50MM TRIS (PH=7.5), REMARK 210 17MM NACL, 5MM DTT; 250 MICRO M REMARK 210 (15N)ARNT PAS-B (356-470) + 1MM REMARK 210 HIF-2ALPHA PAS-B (240-350), 50MM REMARK 210 TRIS (PH=7.5), 17MM NACL, 5MM DTT REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 15N/1H HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 2.3, CNS 1.1, NMRVIEW REMARK 210 5.2.2 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: 15N/1H HSQC WAS USED TO MONITOR CHEMICAL SHIFT REMARK 210 PERTURBATION UPON COMPLEX FORMATION TO IDENTIFY REMARK 210 INTERACTION INTERFACE. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 MET A 14 -102.84 60.51 REMARK 500 1 LEU A 28 -57.26 -123.67 REMARK 500 1 HIS A 46 -173.25 65.65 REMARK 500 1 LEU A 96 72.57 56.55 REMARK 500 1 GLN A 99 -77.09 -89.86 REMARK 500 1 LEU A 108 -65.89 -125.41 REMARK 500 1 GLU A 110 -159.53 -91.38 REMARK 500 1 THR B 32 -64.01 -90.81 REMARK 500 1 LYS B 68 83.70 56.69 REMARK 500 1 TYR B 99 -73.72 -81.02 REMARK 500 1 GLU B 102 129.08 -171.43 REMARK 500 1 VAL B 113 -90.23 -85.74 REMARK 500 2 MET A 14 -102.15 54.68 REMARK 500 2 ASP A 15 32.36 -87.27 REMARK 500 2 PHE A 44 34.17 -148.48 REMARK 500 2 HIS A 46 170.05 70.71 REMARK 500 2 ALA A 47 -64.48 -99.28 REMARK 500 2 LYS A 63 -53.01 -132.17 REMARK 500 2 HIS A 77 30.39 -176.65 REMARK 500 2 LEU A 108 -80.89 -120.92 REMARK 500 2 THR B 10 47.55 -86.33 REMARK 500 2 ARG B 28 19.61 -147.83 REMARK 500 2 LYS B 68 119.42 65.69 REMARK 500 2 TYR B 99 -76.28 -106.06 REMARK 500 3 MET A 14 -102.51 58.73 REMARK 500 3 HIS A 46 149.89 68.80 REMARK 500 3 LYS A 63 -47.52 -140.03 REMARK 500 3 LYS A 76 37.48 -81.76 REMARK 500 3 HIS A 77 27.26 -166.00 REMARK 500 3 GLN A 99 -84.93 -98.91 REMARK 500 3 THR B 10 48.81 -86.99 REMARK 500 3 ARG B 28 -18.16 -148.66 REMARK 500 3 THR B 32 -67.16 -94.44 REMARK 500 3 LYS B 68 125.72 67.57 REMARK 500 3 PRO B 98 39.75 -81.70 REMARK 500 3 TYR B 99 -71.65 -119.52 REMARK 500 4 LEU A 28 -68.63 -91.54 REMARK 500 4 PHE A 44 20.87 -145.02 REMARK 500 4 HIS A 46 121.90 67.00 REMARK 500 4 ASP A 49 49.08 -87.37 REMARK 500 4 ARG B 28 10.55 -151.92 REMARK 500 4 THR B 32 -71.93 -102.84 REMARK 500 4 LYS B 68 101.55 61.06 REMARK 500 4 PRO B 98 47.05 -87.36 REMARK 500 4 TYR B 99 -60.83 -127.17 REMARK 500 5 MET A 14 -98.09 55.98 REMARK 500 5 PHE A 44 29.30 -140.41 REMARK 500 5 HIS A 46 151.87 67.87 REMARK 500 5 GLN A 70 112.35 -36.06 REMARK 500 5 HIS A 77 26.99 178.98 REMARK 500 REMARK 500 THIS ENTRY HAS 210 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2A24 A 6 112 UNP Q99814 EPAS1_HUMAN 242 348 DBREF 2A24 B 7 114 UNP P27540 ARNT_HUMAN 358 465 SEQRES 1 A 107 LYS THR PHE LEU SER ARG HIS SER MET ASP MET LYS PHE SEQRES 2 A 107 THR TYR CYS ASP ASP ARG ILE THR GLU LEU ILE GLY TYR SEQRES 3 A 107 HIS PRO GLU GLU LEU LEU GLY ARG SER ALA TYR GLU PHE SEQRES 4 A 107 TYR HIS ALA LEU ASP SER GLU ASN MET THR LYS SER HIS SEQRES 5 A 107 GLN ASN LEU CYS THR LYS GLY GLN VAL VAL SER GLY GLN SEQRES 6 A 107 TYR ARG MET LEU ALA LYS HIS GLY GLY TYR VAL TRP LEU SEQRES 7 A 107 GLU THR GLN GLY THR VAL ILE TYR ASN PRO ARG ASN LEU SEQRES 8 A 107 GLN PRO GLN CYS ILE MET CYS VAL ASN TYR VAL LEU SER SEQRES 9 A 107 GLU ILE GLU SEQRES 1 B 108 CYS GLN PRO THR GLU PHE ILE SER ARG HIS ASN ILE GLU SEQRES 2 B 108 GLY ILE PHE THR PHE VAL ASP HIS ARG CYS VAL ALA THR SEQRES 3 B 108 VAL GLY TYR GLN PRO GLN GLU LEU LEU GLY LYS ASN ILE SEQRES 4 B 108 VAL GLU PHE CYS HIS PRO GLU ASP GLN GLN LEU LEU ARG SEQRES 5 B 108 ASP SER PHE GLN GLN VAL VAL LYS LEU LYS GLY GLN VAL SEQRES 6 B 108 LEU SER VAL MET PHE ARG PHE ARG SER LYS ASN GLN GLU SEQRES 7 B 108 TRP LEU TRP MET ARG THR SER SER PHE THR PHE GLN ASN SEQRES 8 B 108 PRO TYR SER ASP GLU ILE GLU TYR ILE ILE CYS THR ASN SEQRES 9 B 108 THR ASN VAL LYS HELIX 1 1 ASP A 23 GLU A 27 5 5 HELIX 2 2 HIS A 32 LEU A 37 1 6 HELIX 3 3 SER A 40 TYR A 45 5 6 HELIX 4 4 ASP A 49 THR A 62 1 14 HELIX 5 5 ARG B 28 VAL B 33 1 6 HELIX 6 6 GLN B 36 LEU B 41 1 6 HELIX 7 7 ASN B 44 CYS B 49 5 6 HELIX 8 8 HIS B 50 GLU B 52 5 3 HELIX 9 9 ASP B 53 LYS B 68 1 16 SHEET 1 A 5 LYS A 17 CYS A 21 0 SHEET 2 A 5 THR A 7 SER A 13 -1 N ARG A 11 O TYR A 20 SHEET 3 A 5 GLN A 97 GLU A 112 -1 O ILE A 101 N HIS A 12 SHEET 4 A 5 TYR A 80 ASN A 92 -1 N GLU A 84 O TYR A 106 SHEET 5 A 5 GLN A 65 LEU A 74 -1 N SER A 68 O THR A 85 SHEET 1 B 4 GLU B 11 PHE B 12 0 SHEET 2 B 4 THR B 109 ASN B 112 -1 O ASN B 110 N PHE B 12 SHEET 3 B 4 TRP B 85 GLN B 96 -1 N SER B 91 O THR B 109 SHEET 4 B 4 VAL B 71 ARG B 79 -1 N PHE B 76 O MET B 88 SHEET 1 C 4 GLU B 11 PHE B 12 0 SHEET 2 C 4 THR B 109 ASN B 112 -1 O ASN B 110 N PHE B 12 SHEET 3 C 4 TRP B 85 GLN B 96 -1 N SER B 91 O THR B 109 SHEET 4 C 4 ILE B 103 ILE B 106 -1 O TYR B 105 N PHE B 95 SHEET 1 D 2 SER B 14 HIS B 16 0 SHEET 2 D 2 PHE B 22 VAL B 25 -1 O PHE B 24 N ARG B 15 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1